Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney A Bednar

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|January 26, 2007
Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonistNigel J Liverton, Rodney A Bednar, Bohumil Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2008
The discovery of highly potent CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2009
The identification of potent, orally bioavailable tricyclic CGRP receptor antagonistsIan M Bell, Rodney A Bednar, Halea A Corcoran, et al.
ACS Chemical Neuroscience|July 21, 2012
Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonistsMark E Layton, Michael J Kelly, Kevin J Rodzinak, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2010
Identification of potent, highly constrained CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Journal of Medicinal Chemistry|April 2, 2004
NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazolesJohn A McCauley, Cory R Theberge, Joseph J Romano, et al.
Chemmedchem|May 7, 2009
Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n,n-disubstituted-1,4-diazepane scaffold that promotes sleep in ratsDavid B Whitman, Christopher D Cox, Michael J Breslin, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2006
Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonistsIan M Bell, Rodney A Bednar, John F Fay, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Orally efficacious NR2B-selective NMDA receptor antagonistsChristopher F Claiborne, John A McCauley, Brian E Libby, et al.
Cell Biochemistry and Biophysics|July 8, 2009
Positive allosteric interaction of structurally diverse T-type calcium channel antagonistsVictor N Uebele, Cindy E Nuss, Steven V Fox, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|January 26, 2007
Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonistNigel J Liverton, Rodney A Bednar, Bohumil Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2008
The discovery of highly potent CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2009
The identification of potent, orally bioavailable tricyclic CGRP receptor antagonistsIan M Bell, Rodney A Bednar, Halea A Corcoran, et al.
ACS Chemical Neuroscience|July 21, 2012
Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonistsMark E Layton, Michael J Kelly, Kevin J Rodzinak, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2010
Identification of potent, highly constrained CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Journal of Medicinal Chemistry|April 2, 2004
NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazolesJohn A McCauley, Cory R Theberge, Joseph J Romano, et al.
Chemmedchem|May 7, 2009
Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n,n-disubstituted-1,4-diazepane scaffold that promotes sleep in ratsDavid B Whitman, Christopher D Cox, Michael J Breslin, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2006
Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonistsIan M Bell, Rodney A Bednar, John F Fay, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Orally efficacious NR2B-selective NMDA receptor antagonistsChristopher F Claiborne, John A McCauley, Brian E Libby, et al.
Cell Biochemistry and Biophysics|July 8, 2009
Positive allosteric interaction of structurally diverse T-type calcium channel antagonistsVictor N Uebele, Cindy E Nuss, Steven V Fox, et al.
Pageof 3